» Articles » PMID: 9697729

Granulocyte Colony-stimulating Factor and Antibiotics in the Prophylaxis of a Murine Model of Polymicrobial Peritonitis and Sepsis

Overview
Journal J Infect Dis
Date 1998 Aug 11
PMID 9697729
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Infections that occur after intraabdominal surgery still cause considerable morbidity and mortality despite the administration of prophylactic antibiotics. Increasing the number of neutrophils may also be a prophylactic approach, and granulocyte colony-stimulating factor (G-CSF) has been found to be beneficial in different animal models of peritonitis and sepsis. It is the combination of G-CSF and antibiotics, however, that is clinically relevant. Treatment of mice with G-CSF that was started before cecal ligation and puncture and continued afterward with antibiotics improved survival, decreased splenic bacterial colony-forming units and serum tumor necrosis factor, and increased serum interleukin-10, compared with treatment with antibiotics alone or with saline. Compared with saline, antibiotics alone increased tumor necrosis factor and did not affect interleukin-10. Thus, G-CSF confers onto antibiotics beneficial antiinfectious and antiinflammatory properties. A prophylactic regimen combining G-CSF and antibiotics may help prevent severe infectious complications following intraabdominal surgery.

Citing Articles

Systemic inflammation and protease profile of Afro-Caribbean patients with sepsis.

Borhanjoo P, Singh N, Nath S, Chowdhury M, Swanson C, Kaiser R SAGE Open Med. 2021; 9:20503121211012521.

PMID: 33996084 PMC: 8107660. DOI: 10.1177/20503121211012521.


Modulation of Innate Immunity by G-CSF and Inflammatory Response by LBPK95A Improves the Outcome of Sepsis in a Rat Model.

Fang H, Hua C, Weiss S, Liu A, Cheng W, Claus R J Immunol Res. 2018; 2018:6085095.

PMID: 30525057 PMC: 6247567. DOI: 10.1155/2018/6085095.


Balancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight Sepsis.

Fang H, Jiang W, Cheng J, Lu Y, Liu A, Kan L J Immunol Res. 2016; 2015:187048.

PMID: 26798659 PMC: 4699010. DOI: 10.1155/2015/187048.


Inflammatory mediators in intra-abdominal sepsis or injury - a scoping review.

Xiao Z, Wilson C, Robertson H, Roberts D, Ball C, Jenne C Crit Care. 2015; 19:373.

PMID: 26502877 PMC: 4623902. DOI: 10.1186/s13054-015-1093-4.


Strategies to improve drug development for sepsis.

Fink M, Warren H Nat Rev Drug Discov. 2014; 13(10):741-58.

PMID: 25190187 DOI: 10.1038/nrd4368.